NL8100243A - Werkwijze voor het verkrijgen van menselijk relaxinum. - Google Patents

Werkwijze voor het verkrijgen van menselijk relaxinum. Download PDF

Info

Publication number
NL8100243A
NL8100243A NL8100243A NL8100243A NL8100243A NL 8100243 A NL8100243 A NL 8100243A NL 8100243 A NL8100243 A NL 8100243A NL 8100243 A NL8100243 A NL 8100243A NL 8100243 A NL8100243 A NL 8100243A
Authority
NL
Netherlands
Prior art keywords
relaxinum
human
membranes
chorion
source material
Prior art date
Application number
NL8100243A
Other languages
English (en)
Dutch (nl)
Original Assignee
Hypolab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hypolab Sa filed Critical Hypolab Sa
Publication of NL8100243A publication Critical patent/NL8100243A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/64—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/851—Placenta; amniotic fluid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/852—Sperm
    • Y10S530/853—Ovary; eggs; embryos

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NL8100243A 1980-02-01 1981-01-20 Werkwijze voor het verkrijgen van menselijk relaxinum. NL8100243A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11744480 1980-02-01
US06/117,444 US4267101A (en) 1980-02-01 1980-02-01 Process for obtaining human relaxin from fetal membranes

Publications (1)

Publication Number Publication Date
NL8100243A true NL8100243A (nl) 1981-09-01

Family

ID=22372986

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8100243A NL8100243A (nl) 1980-02-01 1981-01-20 Werkwijze voor het verkrijgen van menselijk relaxinum.

Country Status (18)

Country Link
US (1) US4267101A (fr)
JP (1) JPS56127315A (fr)
AR (2) AR227907A1 (fr)
AT (1) AT372856B (fr)
AU (1) AU540310B2 (fr)
BE (1) BE887324A (fr)
CA (1) CA1143286A (fr)
CH (1) CH647530A5 (fr)
DE (1) DE3102487C2 (fr)
DK (1) DK44181A (fr)
ES (1) ES8203914A1 (fr)
FR (1) FR2475047A1 (fr)
GB (1) GB2068383B (fr)
IL (1) IL61931A (fr)
IT (1) IT8147648A0 (fr)
NL (1) NL8100243A (fr)
SE (1) SE8100614L (fr)
ZA (1) ZA81374B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5320953A (en) * 1982-08-12 1994-06-14 Howard Florey Institute Of Experimental Physiology And Medicine Process for synthesizing human H1-prorelaxin, H1-relaxin and fusion proteins thereof
US5053488A (en) * 1982-08-12 1991-10-01 Howard Florey Institute Of Experimental Physiology & Medicine Molecular cloning and characterization of a gene sequence coding for human relaxin
ATE78042T1 (de) * 1982-08-12 1992-07-15 Florey Howard Inst Analoge des humanen relaxins.
DE3236264A1 (de) * 1982-09-30 1984-04-05 Serono Pharmazeutische Präparate GmbH, 7800 Freiburg Verfahren zur gewinnung von relaxin
US5023321A (en) * 1982-12-13 1991-06-11 Howard Florey Institute Of Experimental Physiology & Medicine Molecular cloning and characterization of a further gene sequence coding for human relaxin
IL70414A (en) * 1982-12-13 1991-06-10 Florey Howard Inst Polypeptide having human h2-relaxin activity,double-stranded dna fragments coding therefor,vectors containing the dna fragments and methods for preparing the polypeptide,dna fragments and vectors
EP0260149A1 (fr) * 1986-09-12 1988-03-16 Howard Florey Institute Of Experimental Physiology And Medicine Prorélaxine humaine pour utilisation thérapeutique
ATE88352T1 (de) * 1988-02-26 1993-05-15 Genentech Inc Humanes relaxinpraeparat.
US6348327B1 (en) * 1991-12-06 2002-02-19 Genentech, Inc. Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells
US5612051A (en) * 1995-11-17 1997-03-18 Yue; Samuel K. Method of treating involuntary muscle dysfunction with relaxin hormone
US6251863B1 (en) 1998-09-08 2001-06-26 Samuel K. Yue Method of preventing and treating symptoms of aging and neurodegenerative dysfunctions with relaxin
WO2005115435A2 (fr) * 2004-04-30 2005-12-08 Bas Medical, Inc. Methodes et compositions de lutte contre les maladies de la croissance foetale par modulation de la relaxine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2852432A (en) * 1953-08-11 1958-09-16 Warner Lambert Pharmaceutical Process for purification of relaxin by ion exchange
US2852431A (en) * 1954-05-17 1958-09-16 Warner Lambert Pharmaceutical Process for the extraction and purification of relaxin using trichloracetic acid
US2930737A (en) * 1955-11-15 1960-03-29 Princeton Lab Inc Process for the isolation of relaxin using glacial acetic acid
US2995494A (en) * 1957-12-27 1961-08-08 Ortho Pharma Corp Process for purifying relaxin

Also Published As

Publication number Publication date
GB2068383B (en) 1983-05-11
CA1143286A (fr) 1983-03-22
IT8147648A0 (it) 1981-01-28
ZA81374B (en) 1982-08-25
CH647530A5 (de) 1985-01-31
BE887324A (fr) 1981-05-14
AU6661481A (en) 1981-08-06
GB2068383A (en) 1981-08-12
FR2475047B1 (fr) 1983-07-29
IL61931A (en) 1984-06-29
AU540310B2 (en) 1984-11-08
JPS6157809B2 (fr) 1986-12-09
ATA26281A (de) 1983-04-15
AR227959A1 (es) 1982-12-30
AR227907A1 (es) 1982-12-30
IL61931A0 (en) 1981-02-27
SE8100614L (sv) 1981-08-02
AT372856B (de) 1983-11-25
DE3102487A1 (de) 1982-01-07
ES498941A0 (es) 1982-05-01
JPS56127315A (en) 1981-10-06
ES8203914A1 (es) 1982-05-01
DK44181A (da) 1981-08-02
DE3102487C2 (de) 1983-06-16
FR2475047A1 (fr) 1981-08-07
US4267101A (en) 1981-05-12

Similar Documents

Publication Publication Date Title
Gundersen et al. Biological activity of blood insulin complexes examined by rat diaphragm tissue assay.
Cleary et al. The changes in chemical composition during development of the bovine nuchal ligament
Wiener et al. An electron microscopic study of the homograft reaction
Walter et al. Leucylglycinamide released from oxytocin by human uterine enzyme
BIGAZZI et al. Relaxin in human decidua
DE60030450T2 (de) Von MUC-1 abgeleitete Peptide
Bloor et al. Expression of keratin K2e in cutaneous and oral lesions: association with keratinocyte activation, proliferation, and keratinization
NL8100243A (nl) Werkwijze voor het verkrijgen van menselijk relaxinum.
Okamoto et al. Expression of human placenta alkaline phosphatase in placenta during pregnancy
Brewer et al. Detection of oncomodulin, an oncodevelopmental protein in human placenta and choriocarcinoma cell lines
Levine et al. The first human blood,---/---, which lacks the ‘D-like’antigen
EP0107045A1 (fr) Procédé pour obtenir de relaxin á partir de lait
Kanatani Presence of 1‐methyladenine in sea urchin gonad and its relation to oocyte maturation
Gröschel-Stewart et al. Immunological evidence for human myosin isoenzymes
Barnes The antigenic nature of male accessory glands of reproduction
Middleton Jr et al. Distribution and properties of anaphylactic and venom-induced slow-reacting-substance and histamine in guinea pigs
Nilsson et al. Characterization and localization of specific oestrogen binding in the human thymus
Selkirk et al. Localization, turnover and conservation of gp15/400 in different stages of Brugia malayi
Pasteels Tissue culture of human hypophyses: evidence of a specific prolactin in man
Hsi et al. Characterization of antibodies to antigens of the human amnion
Asch et al. Heterogeneity of keratin expression in mouse mammary hyperplastic alveolar nodules and adenocarcinomas
US3170839A (en) Culture process in vitro placental tissue growth medium
Wathes et al. Identification of relaxin in the placenta of the ewe
Tsonis et al. Secretion of bioactive inhibin by the ovary of the Booroola Merino ewe with or without a copy of the fecundity (F) gene.
Iversen et al. Rabbit antibodies against the major internal protein of a retrovirus-like particle bind to epidermal cells in psoriatic skin

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed